FDA Approves First Myelofibrosis Drug in Nearly a Decade
The U.S. Food and Drug Administration approved Impact’s Inrebic for the treatment for adult patients with certain types of myelofibrosis, cancers of the bone marrow.
The Home of the Life Sciences Industry
Explore Latest News
Report: Projected Sales of 10 Top-Selling Drugs Through 2024
Although some of the top-selling drugs in the world are facing patent cliffs between now and then, many of them are still projected to continue being big sellers between now and 2024.
- FDA Approves Genentech's Rozlytrek for Two Rare Types of Cancer
- Research Roundup: Radical Insights into Cellular Dark Matter and More
- BIO CEO Warns About Government Pricing Measures at CLSA Event
- Experimental Endoscope Captures 3D Images Smaller than a Single Cell
- A Family Affair: Kaspar Brothers Replaced at AveXis Amid Data Manipulation Scandal
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.